Drug Profile
Amphotericin B liposomal polyethylene glycol
Alternative Names: Amphotericin B liposomal-PEG; Amphotericin B-PEG; PEG amphotericin B; PEG amphotericin B liposomalLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antifungals; Antiprotozoals; Antipyretics; Macrolides
- Mechanism of Action Cell membrane permeability enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 21 Jun 2001 No-Development-Reported for Mycoses in Netherlands (Unknown route)
- 30 Dec 1997 New profile
- 30 Dec 1997 Preclinical development for Mycoses in Netherlands (Unknown route)